Compare Quest Diagnostics Inc (DGX) vs DigitalOcean Holdings Inc (DOCN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs DigitalOcean Holdings Inc — how do they compare? Quest Diagnostics Inc trades at $238.51 (market cap $26.21B), while DigitalOcean Holdings Inc trades at $133.78 (market cap $14.21B). The key difference: Quest Diagnostics Inc is the larger of the two by market cap, and Quest Diagnostics Inc pays a 1.45% dividend while DigitalOcean Holdings Inc pays none. Which is the better fit depends on your goals.
| DGX | DOCN | |
|---|---|---|
Market Cap | $26.21B | $14.21B |
Sector | Health | Technology |
52-Week High | $238.50 | $181.29 |
52-Week Low | $173.49 | $29.99 |
Enterprise Value | $31.97B | $14.97B |
Dividend Yield | 1.45% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $237.24, down 0.16% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $3.12 and raising its full-year outlook, driven by robust testing demand. Revenue grew to $11.04B in 2025, with net income of $992M, though margins face pressure from lower-margin deals and rising costs.
The outlook is positive due to raised guidance and AI integration enhancing efficiency, but risks include debt levels and margin compression. Analysts maintain a cautious buy stance with a $249.50 price target, indicating modest upside potential from current levels amid competitive and cost challenges.
DigitalOcean (DOCN) trades at $133.03, up 2.54% today, with a bearish technical signal but strong fundamental momentum. Recent Q2 2026 earnings beat expectations with 29% revenue growth, driven by AI-native cloud demand. The stock shows high valuation ratios (P/E 54.94, P/S 13.62) and robust profitability (net margin 23.27%, ROE 62.27%). Analyst consensus is bullish with a $173.71 price target, though technical indicators suggest near-term resistance at $134.
Outlook is positive due to accelerating AI-driven growth and raised 2027 guidance, but risks include high debt levels and valuation concerns. The stock offers upside if execution continues, yet volatility near resistance may prompt consolidation. Investors should weigh strong earnings against technical bearishness and leverage exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About DigitalOcean Holdings Inc
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →
